Khandelwal Shweta, Kondal Dimple, Gupta Ruby, Chaudhry Monica, Dutta Soumam, Ramakrishnan Lakshmy, Patil Kamal, Swamy M K, Prabhakaran Dorairaj, Tandon Nikhil, Ramakrishnan Usha, Stein Aryeh D
Department of Public Health Nutrition, Public Health Foundation of India, Gurugram, India.
Department of Biostatistics, Centre for Chronic Disease Control, Gurugram, India.
Curr Dev Nutr. 2023 Sep 29;7(10):102010. doi: 10.1016/j.cdnut.2023.102010. eCollection 2023 Oct.
Low concentrations of docosahexaenoic acid (DHA) or high n-6 (ω-6):n-3 ratio in pregnant women is associated with poor fetal growth velocity and suboptimal neurodevelopment. However, there is a lack of data on levels of important n-6 and n-3 fatty acids (FAs) at different time points during pregnancy and lactation from India. Data on how much DHA is transferred during actual supplementation are also scarce.
We report the concentrations of n-6 and n-3 FAs in maternal and infant blood and in breast milk following maternal supplementation with DHA or placebo.
A total of 957 pregnant women (≤20 wk) from Belagavi, Karnataka, were randomly assigned to receive either 400 mg/d of algal DHA or placebo through 6 mo postpartum. Blood samples were collected from the mother at recruitment/baseline, delivery, and 6 mo postpartum and from the infant at birth (cord) and 12 mo (venous). Breast milk samples were collected from a subsample at delivery, 1 mo and 6 mo postpartum. The FA profile was analyzed using gas chromatography.
The concentration of DHA appeared to be higher in erythrocyte and breast milk samples of the DHA-supplemented group at all subsequent time points. The n-6:n-3 ratio was lower among women in the DHA group at delivery [DHA: 4.08 (1.79); placebo: 5.84 (3.57); < 0.001] and at 6 mo postpartum [DHA: 5.34 (2.64); placebo: 7.69 (2.9); < 0.001]. Infants of DHA-supplemented mothers also had a lower n-6:n-3 ratio at delivery and 12 mo. The n-6:n-3 ratio of breast milk increased from delivery through 1 to 6 mo but remained lower in the DHA-supplemented group than in the placebo.
Maternal DHA supplementation with 400 mg/d from early pregnancy through 6 mo postpartum significantly increased circulating DHA in breast milk and infant erythrocyte, whereas decreased erythrocyte and breast milk n-6:n-3 ratio. However, maternal supplementation did not get the ratio to the recommended levels.
孕妇体内二十二碳六烯酸(DHA)浓度较低或n-6(ω-6):n-3比例较高与胎儿生长速度缓慢及神经发育欠佳有关。然而,关于印度孕妇孕期和哺乳期不同时间点重要的n-6和n-3脂肪酸(FAs)水平的数据尚缺。关于实际补充过程中DHA的转移量的数据也很稀少。
我们报告了孕妇补充DHA或安慰剂后母婴血液及母乳中n-6和n-3 FAs的浓度。
来自卡纳塔克邦贝拉尔加维的957名孕妇(孕周≤20周)被随机分配,从孕期直至产后6个月分别接受400mg/d的藻油DHA或安慰剂。在招募/基线期、分娩时及产后6个月采集母亲的血样,在出生时(脐带血)及12个月(静脉血)采集婴儿的血样。在分娩时、产后1个月及6个月从一个子样本中采集母乳样本。使用气相色谱法分析脂肪酸谱。
在所有后续时间点,补充DHA组的红细胞和母乳样本中DHA浓度似乎更高。DHA组女性在分娩时[n-6:n-3比例,DHA组: 4.08(1.79);安慰剂组:5.84(3.57);P<0.001]及产后6个月时[n-6:n-3比例,DHA组:5.34(2.64);安慰剂组:7.69(2.9);P<0.001]的n-6:n-3比例更低。补充DHA母亲的婴儿在分娩时及12个月时的n-6:n-3比例也更低。母乳的n-6:n-3比例从分娩到产后1个月再到6个月增加,但补充DHA组仍低于安慰剂组。
从孕早期至产后6个月每天补充400mg的母体DHA显著增加了母乳和婴儿红细胞中的循环DHA,同时降低了红细胞和母乳中的n-6:n-3比例。然而,母体补充并未使该比例达到推荐水平。